Biotin-LC Alpha-Synuclein (41-60) Peptide

Product Name
Biotin-LC Alpha-Synuclein (41-60) Peptide
Product Quantity
4 mg
Catalog Number
LT8707
Sequence
GSKTKEGVVHGVATVAEKTK
Gly-Ser-Lys-Thr-Lys-Glu-Gly-Val-Val-His-Gly-Val-Ala-Thr-Val-Ala-Glu-Lys-Thr-Lys
Purity
>95%
Modifications
LCbiot, 1mg/vial
Peptide Type
Human alpha-synuclein research fragment
Scientific Background

If alpha-synuclein has a pathogenic hotspot, residues 41 to 60 is it. Within this single twenty-residue stretch sit the sites of E46K, H50Q, G51D and A53T, and the segment runs up to the boundary of the hydrophobic NAC region beginning near residue 61.

A53T was the first SNCA mutation associated with familial Parkinson's disease. More striking is that G51D, two positions away, has been linked to a phenotype overlapping multiple system atrophy rather than classical Parkinson's, so substitutions separated by a couple of residues can produce clinically distinguishable disease. That sensitivity is what makes the window interesting to work on and difficult to generalise about.

Its position at the domain junction gives a second use. Compared against a peptide extending further into the hydrophobic core, it separates binding that depends on the mutation-dense N-terminal stretch from binding that requires the aggregation segment beyond it — a distinction that full-length protein cannot resolve, since both regions are present.

Research Applications
  • Studies spanning the A53T, G51D, H50Q and E46K mutation cluster
  • Mapping where the N-terminal domain gives way to the NAC region
  • Distinguishing Parkinson-associated from multiple-system-atrophy-associated variants
  • Competition assays against full-length alpha-synuclein
  • Epitope localisation alongside the 31-50 and 51-70 peptides
References

1. Initiation and progression of alpha-synuclein pathology in Parkinson's disease. Cellular and Molecular Life Sciences (2022). CMLS 2022

2. The Parkinson disease gene SNCA: evolutionary and structural insights with pathological implication. Scientific Reports (2016). Sci Rep 2016

3. Alpha-synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy? Acta Neuropathologica (2013). Acta Neuropathol 2013

  • 1 Units in Stock
Ask a Question

Add to Cart: